Adherence and Quality of Life Assessment in Patients With Asthma Treatment With Budesonide/Formoterol via the Elpenhaler Device

The COMPLETE Study

Konstantinos P. Exarchos; Nikoletta Rovina; George Krommidas; Dimitrios Latsios; Athena Gogali; Konstantinos Kostikas

Disclosures

BMC Pulm Med. 2022;22(254) 

In This Article

Conclusions

In this study of 716 asthmatic patients, treatment with FDC of budesonide/formoterol via the Elpenhaler device was associated with medium to high adherence in the majority of patients (~ 80%), with improvement in asthma-related quality of life and lung function over 6 months. These improvements were more prominent in patients with higher adherence.

processing....